How to Donate

Every contribution brings us closer to better treatments — 
and real hope for those affected by brain tumours and epilepsy. 
Your support helps drive the research that changes lives.

You can donate via credit card or direct bank transfer. Please note, all credit card donations are subject to a small third party fee which will automatically be deducted from your donation, whilst direct bank transfer incurs no fee.

Direct Bank Transfer Details:

Victorian Centre for Brain Tumour 
and Epilepsy Research LTD
BSB: 062 000
ACC: 2115 5526

All donation over $2 are tax deductible.

Our Projects

At the Victorian Centre for Brain Tumour and Epilepsy Research (CBER), our projects 
are designed to drive tangible improvements in the care, treatment, and outcomes of people living with brain tumours and epilepsy. We focus on high-impact clinical innovation, translational research, 
and targeted therapy development. 
Our current initiatives include:

CBER is actively funding and supporting the introduction
of Laser Interstitial Thermal Therapy (LITT) for patients with brain tumours and medically refractory epilepsy.

LITT is a minimally invasive surgical technique that uses laser energy to precisely target and destroy abnormal brain tissue while sparing surrounding healthy structures. For patients with deep-seated tumours or epilepsy foci in eloquent brain regions, LITT offers shorter hospital stays, reduced surgical risks, and faster recovery compared to traditional open surgery. Despite its demonstrated clinical advantages and growing use internationally, LITT is not currently funded by the Australian government. CBER is working to close this gap—helping to establish access to this innovative therapy for Victorian patients through philanthropic support, advocacy, and infrastructure development.

LITT in the media

Read less

Our team is currently currently researching a novel surgical therapy for treating and slowing down the spread of Glioblastoma.

Our goal is to take this concept from a pre-clinical model to a clinical trial over the next three years.

Read less